These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 14711311)

  • 1. Synthesis and structure-activity relationship for a novel class of potent and selective carbamoyl-triazole based inhibitors of hormone sensitive lipase.
    Ebdrup S; Sørensen LG; Olsen OH; Jacobsen P
    J Med Chem; 2004 Jan; 47(2):400-10. PubMed ID: 14711311
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structure-reactivity relationships for the inhibition mechanism at the second alkyl-chain-binding site of cholesterol esterase and lipase.
    Lin G; Shieh CT; Ho HC; Chouhwang JY; Lin WY; Lu CP
    Biochemistry; 1999 Aug; 38(31):9971-81. PubMed ID: 10433704
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Carbazates as potent inhibitors of hormone-sensitive lipase.
    de Jong JC; Sørensen LG; Tornqvist H; Jacobsen P
    Bioorg Med Chem Lett; 2004 Apr; 14(7):1741-4. PubMed ID: 15026062
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structure-activity relationship for aryl and heteroaryl boronic acid inhibitors of hormone-sensitive lipase.
    Ebdrup S; Jacobsen P; Farrington AD; Vedsø P
    Bioorg Med Chem; 2005 Mar; 13(6):2305-12. PubMed ID: 15727879
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combining ligand-based pharmacophore modeling, quantitative structure-activity relationship analysis and in silico screening for the discovery of new potent hormone sensitive lipase inhibitors.
    Taha MO; Dahabiyeh LA; Bustanji Y; Zalloum H; Saleh S
    J Med Chem; 2008 Oct; 51(20):6478-94. PubMed ID: 18808096
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pyrrolopyrazinedione-based inhibitors of human hormone-sensitive lipase.
    Slee DH; Bhat AS; Nguyen TN; Kish M; Lundeen K; Newman MJ; McConnell SJ
    J Med Chem; 2003 Mar; 46(7):1120-2. PubMed ID: 12646020
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of an inhibitor to identify members of the hormone-sensitive lipase family.
    Ben Ali Y; Chahinian H; Petry S; Muller G; Lebrun R; Verger R; Carrière F; Mandrich L; Rossi M; Manco G; Sarda L; Abousalham A
    Biochemistry; 2006 Nov; 45(47):14183-91. PubMed ID: 17115713
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro SAR of (5-(2H)-isoxazolonyl) ureas, potent inhibitors of hormone-sensitive lipase.
    Lowe DB; Magnuson S; Qi N; Campbell AM; Cook J; Hong Z; Wang M; Rodriguez M; Achebe F; Kluender H; Wong WC; Bullock WH; Salhanick AI; Witman-Jones T; Bowling ME; Keiper C; Clairmont KB
    Bioorg Med Chem Lett; 2004 Jun; 14(12):3155-9. PubMed ID: 15149665
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis and cyclooxygenase inhibition of various (aryl-1,2,3-triazole-1-yl)-methanesulfonylphenyl derivatives.
    Wuest F; Tang X; Kniess T; Pietzsch J; Suresh M
    Bioorg Med Chem; 2009 Feb; 17(3):1146-51. PubMed ID: 19157881
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Discovery of potent inhibitors of dihydroneopterin aldolase using CrystaLEAD high-throughput X-ray crystallographic screening and structure-directed lead optimization.
    Sanders WJ; Nienaber VL; Lerner CG; McCall JO; Merrick SM; Swanson SJ; Harlan JE; Stoll VS; Stamper GF; Betz SF; Condroski KR; Meadows RP; Severin JM; Walter KA; Magdalinos P; Jakob CG; Wagner R; Beutel BA
    J Med Chem; 2004 Mar; 47(7):1709-18. PubMed ID: 15027862
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The molecular mechanism of human hormone-sensitive lipase inhibition by substituted 3-phenyl-5-alkoxy-1,3,4-oxadiazol-2-ones.
    Ali YB; Verger R; Carrière F; Petry S; Muller G; Abousalham A
    Biochimie; 2012 Jan; 94(1):137-45. PubMed ID: 22008857
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis, 3D-QSAR, and docking studies of 1-phenyl-1H-1,2,3-triazoles as selective antagonists for beta3 over alpha1beta2gamma2 GABA receptors.
    Alam MS; Huang J; Ozoe F; Matsumura F; Ozoe Y
    Bioorg Med Chem; 2007 Aug; 15(15):5090-104. PubMed ID: 17544280
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis and structure-activity relationship for a novel class of potent and selective carbamate-based inhibitors of hormone selective lipase with acute in vivo antilipolytic effects.
    Ebdrup S; Refsgaard HH; Fledelius C; Jacobsen P
    J Med Chem; 2007 Nov; 50(22):5449-56. PubMed ID: 17918819
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Highly potent inhibitors of methionine aminopeptidase-2 based on a 1,2,4-triazole pharmacophore.
    Marino JP; Fisher PW; Hofmann GA; Kirkpatrick RB; Janson CA; Johnson RK; Ma C; Mattern M; Meek TD; Ryan MD; Schulz C; Smith WW; Tew DG; Tomazek TA; Veber DF; Xiong WC; Yamamoto Y; Yamashita K; Yang G; Thompson SK
    J Med Chem; 2007 Aug; 50(16):3777-85. PubMed ID: 17636946
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phosphaisocoumarins as a new class of potent inhibitors for pancreatic cholesterol esterase.
    Li B; Zhou B; Lu H; Ma L; Peng AY
    Eur J Med Chem; 2010 May; 45(5):1955-63. PubMed ID: 20149492
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Might the kinetic behavior of hormone-sensitive lipase reflect the absence of the lid domain?
    Ben Ali Y; Chahinian H; Petry S; Muller G; Carrière F; Verger R; Abousalham A
    Biochemistry; 2004 Jul; 43(29):9298-306. PubMed ID: 15260473
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis and in vitro characterization of 1-(4-aminofurazan-3-yl)-5-dialkylaminomethyl-1H-[1,2,3]triazole-4-carboxylic acid derivatives. A new class of selective GSK-3 inhibitors.
    Olesen PH; Sørensen AR; Ursø B; Kurtzhals P; Bowler AN; Ehrbar U; Hansen BF
    J Med Chem; 2003 Jul; 46(15):3333-41. PubMed ID: 12852764
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis and structure-activity relationships of 1,2,4-triazoles as a novel class of potent tubulin polymerization inhibitors.
    Ouyang X; Chen X; Piatnitski EL; Kiselyov AS; He HY; Mao Y; Pattaropong V; Yu Y; Kim KH; Kincaid J; Smith L; Wong WC; Lee SP; Milligan DL; Malikzay A; Fleming J; Gerlak J; Deevi D; Doody JF; Chiang HH; Patel SN; Wang Y; Rolser RL; Kussie P; Labelle M; Tuma MC
    Bioorg Med Chem Lett; 2005 Dec; 15(23):5154-9. PubMed ID: 16198562
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rational design, synthesis, and structure-activity relationships of aryltriazoles as novel corticotropin-releasing factor-1 receptor antagonists.
    Lowe RF; Nelson J; Dang TN; Crowe PD; Pahuja A; McCarthy JR; Grigoriadis DE; Conlon P; Saunders J; Chen C; Szabo T; Chen TK; Bozigian H
    J Med Chem; 2005 Mar; 48(5):1540-9. PubMed ID: 15743196
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of a novel boronic acid as a potent, selective, and orally active hormone sensitive lipase inhibitor.
    Ogiyama T; Yamaguchi M; Kurikawa N; Honzumi S; Yamamoto Y; Sugiyama D; Inoue S
    Bioorg Med Chem; 2016 Aug; 24(16):3801-7. PubMed ID: 27338659
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.